Affiliation:
1. Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University)
2. Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University); Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of Russia
3. Central Clinical Hospital of Civil Aviation
Abstract
Immediacy of the problem of combination therapy of respiratory diseases in paediatric practice is caused by their multifactorial pathogenesis in children and the need to achieve a high clinical effect in the use of drugs at relatively low doses and with minimum risks of serious adverse effects and drug interactions. The fixed-dose combination of salbutamol, bromhexine and guaifenesin produced in the form of tablets and syrup fully meets these requirements, which makes it possible to use it in children and adults with acute, chronic infectious (ARVI, bacterial pneumonia, respiratory tuberculosis, etc.) and non-infectious (bronchial asthma, pulmonary cystic fibrosis, primary ciliary dyskinesia, etc.) diseases.
Reference25 articles.
1. Anoshkina EV, Gammel IV, Kononova SV. Dynamics of respiratory disease morbidity of the child population in the country. Meditsinskiy Almanakh, 2018, 3 (54).
2. Volkov KS, NamazovaBaranova LS, Alekseeva AA, Barannik VA, Tomilova AYu, Vishneva EA, Efendiyeva KE, Muradova OI. Cough in children: etiology, diagnostic features and approaches to therapy. VSP, 2014, 2.
3. Chang AB. Cough. Pediatr Clin North Am, 2009, 56(1): 19-31. ix. doi: 10.1016/j.pcl.2008.10.002.
4. Shields MD, Thavagnanam S. The difficult coughing child: prolonged acute cough in children. Cough, 2013, 10, 9(1): 11. doi: 10.1186/17459974-9-11.
5. Seto WH, Conly JM, Pessoa-Silva CL et al. Infection prevention and control measures for acute respiratory infections in healthcare settings: an update. East Mediterr Health J, 2013, 19(Suppl. 1): 39–47.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献